Business ModelCryo-Cell's core business of processing and storing stem cells has high margins and mostly recurring revenue, contributing to its financial attractiveness.
Dividend YieldThe company maintains a high dividend yield of 18.1%, which is attractive to investors seeking regular income.
Financial PerformanceCryo-Cell International reported a strong EBITDA performance, demonstrating resilience despite a slight decline in overall revenue.